Notify me when Bihua Chen files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HLXB | Helix Acquisition Corp. II | Class A ordinary shares, $0.0001 par value per share | 31.59% | $81.4M | 7.39M | Bihua Chen | Feb 28, 2025 | ||
| BridgeBio Oncology Therapeutics, Inc. | Common Stock | 22.6% | 17.9M | Bihua Chen | Aug 11, 2025 | ||||
| MLTX | MoonLake Immunotherapeutics | Class A Ordinary Shares | 3.14% | $108M | 1.99M | Chen Bihua | Sep 30, 2025 | ||
| BMEA | Biomea Fusion, Inc. | Common Stock | 1.53% | $2.14M | -$5.3M | 1.06M | -71.2% | Chen Bihua | Oct 22, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|